Irish-German OneProjects gets $17m pump for heart imaging tech
Summary
The medtech’s Verafeye device helps doctors treat atrial fibrillation using advanced imaging and data analytics. Last year, the medial device start-up raised €11m in Series A funding to support the development of its Verafeye technology, which is designed to treat atrial fibrillation. The Government of Ireland’s Disruptive Technologies Innovation Fund granted OneProjects $6m (€5.1m) in its awards allocation announced in April. Atrial fibrillation is characterised by irregular heartbeats caused by chaotic electric signals overriding the heart’s natural rhythm. “As a European company with offices in Dublin and Munich, we appreciate having exposure and access to these top-tier investors who will enable us to bring Verafeye to market and to develop the next generations of our platform technology,” Lahart added.